- Home
- GCO vs CRGX Comparison
GCO vs CRGX Comparison
Compare GCO & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCO
- CRGX
- Stock Information
- Founded
- GCO 1924
- CRGX 2021
- Country
- GCO United States
- CRGX United States
- Employees
- GCO N/A
- CRGX N/A
- Industry
- GCO Clothing/Shoe/Accessory Stores
- CRGX
- Sector
- GCO Consumer Discretionary
- CRGX
- Exchange
- GCO Nasdaq
- CRGX Nasdaq
- Market Cap
- GCO 212.2M
- CRGX 190.0M
- IPO Year
- GCO N/A
- CRGX 2023
- Fundamental
- Price
- GCO $23.63
- CRGX $4.59
- Analyst Decision
- GCO Hold
- CRGX Hold
- Analyst Count
- GCO 2
- CRGX 7
- Target Price
- GCO $24.50
- CRGX $5.33
- AVG Volume (30 Days)
- GCO 264.0K
- CRGX 1.9M
- Earning Date
- GCO 09-05-2025
- CRGX 08-11-2025
- Dividend Yield
- GCO N/A
- CRGX N/A
- EPS Growth
- GCO N/A
- CRGX N/A
- EPS
- GCO N/A
- CRGX N/A
- Revenue
- GCO $2,341,438,000.00
- CRGX N/A
- Revenue This Year
- GCO $2.53
- CRGX $57.81
- Revenue Next Year
- GCO $2.01
- CRGX N/A
- P/E Ratio
- GCO N/A
- CRGX N/A
- Revenue Growth
- GCO 1.85
- CRGX N/A
- 52 Week Low
- GCO $16.19
- CRGX $3.00
- 52 Week High
- GCO $44.80
- CRGX $25.45
- Technical
- Relative Strength Index (RSI)
- GCO 62.21
- CRGX 61.56
- Support Level
- GCO $21.26
- CRGX $4.32
- Resistance Level
- GCO $22.57
- CRGX $4.63
- Average True Range (ATR)
- GCO 1.10
- CRGX 0.16
- MACD
- GCO 0.29
- CRGX 0.04
- Stochastic Oscillator
- GCO 90.42
- CRGX 76.44
About GCO Genesco Inc.
Genesco Inc. sells footwear, headwear, sports apparel, and accessories through four main segments. The Journeys Group generates the highest revenue, encompassing the Journeys, Journeys Kidz, and Little Burgundy brands, along with e-commerce and catalog sales. The Schuh Group targets teenagers and young adults aged 16 to 24, focusing on casual and athletic footwear. The Johnston & Murphy Group operates retail shops and factory stores across the United States. Finally, the Genesco Brands Group designs and sources licensed footwear for brands like Levi's, Dockers, and G.H. Bass.
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.